Nearly 27% of patients experienced a complete response; median duration of response not reached; only 1 patient experienced a Grade >3 immune-related adverse event Second Largest Prospective Study...

VIA Labs, Inc. (VLI), a leading supplier of USB4, DisplayPort, SuperSpeed USB, and USB Power Delivery Controllers, today announced the launch of its first MST Hub VL610 at Computex 2026. Following...

New EDLA-certified displays deliver seamless access to Google services, enhanced security and flexible all-in-one collaboration MONTVALE, N.J., May 26, 2026 /PRNewswire/ -- From boardrooms to...

>6,100 participants with and without cancer have been enrolled, spanning 20 cancer types FOSTER CITY, Calif., May 26, 2026 /PRNewswire/ -- Adela, Inc., an innovator in blood testing for molecular...

Data highlight how screening and diagnostics enable earlier detection, more precise treatment decisions, and improved patient outcomes from risk to remission New MRD data from the PARTNER study...

San Diego State University highlights a proactive approach to LMS data resilience by leveraging Canvas Archiving & DataX CHANDLER, Ariz., May 26, 2026 /PRNewswire/ -- K16 Solutions Inc., the...

Urban Poling Inc., in partnership with PWR! (Parkinson Wellness Recovery), is pleased to announce its participation in the World Parkinson's Conference, to be held at the Phoenix Convention Centre...

Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at...

Watkins-based Kazmira Therapeutics launches a first-of-its-kind telehealth platform for prescription cannabis. DENVER, May 26, 2026 /PRNewswire/ -- Kazmira Therapeutics, the company behind...

24% Objective Response Rate, with an average of 21.1 month Duration of Response in responders, and favorable safety profile signals potential of LYMPHIR to augment immune checkpoint inhibitor efficacy